Physician-scientists from Cedars-Sinai’s Kao Autoimmunity Institute and Division of Rheumatology will present a range of research and clinical findings during the American College of Rheumatology Convergence 2024 in Washington, D.C., Nov. 14-19. Both Francesco Boin, MD, director of the Division of Rheumatology and director of…
Tag: Kao Autoimmunity Institute
Scleroderma Awareness Month
Scleroderma is an autoimmune disease characterized by thickening and scarring of the skin and vital organs, and the narrowing of the blood vessels which lead to poor circulation.
Association of American Physicians Taps Cedars-Sinai Leader as President-Elect
Physician-scientist Paul Noble, MD, chair of the Department of Medicine at Cedars-Sinai, was named president-elect of the Association of American Physicians (AAP) at the group’s annual meeting in Chicago on April 22.
August Research Highlights
A Roundup of the Latest Medical Discoveries and Faculty News at Cedars-Sinai
International Leader in Autoimmune Research to Lead Cedars-Sinai Institute
Nunzio Bottini, MD, PhD, whose groundbreaking research focuses on the role of a group of proteins in the development of rheumatic diseases, has joined Cedars-Sinai as the inaugural director of the Kao Autoimmunity Institute.
Prominent Rheumatologist to Create Scleroderma Program at Kao Institute
Nationally recognized rheumatology expert Francesco Boin, MD, has been appointed director of the division of Rheumatology and director of the new Scleroderma Program at Cedars-Sinai. Boin is an accomplished and widely published investigator of autoimmune diseases, with a reputation for clinical excellence and a multidisciplinary approach to patient care.